LexDanaLexDanabeta
Inventor

Giuseppe Claudio Viscomi

Inventor
Bologna, IT

Overview

43→
Patents
1984–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 43 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
A61KPreparations for medical, dental or toiletry purposes22%
C07DHeterocyclic compounds21%
C07BGeneral methods of organic chemistry12%
Y02ATechnologies for adaptation to climate change8%
C07KPeptides3%
H05BElectric heating3%
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for1%
A23VIndexing scheme relating to foods, foodstuffs or non-alcoholic beverages and lactic or propionic acid bacteria used in foodstuffs or food preparation1%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
PatentTitleYear
10,793,925None202010,703,763Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations202010,428,086Solvated crystal form of rifaximin, production, compositions and uses thereof201910,285,944Gastroresistant pharmaceutical formulations containing rifaximin201910,280,177Use of polyols to obtain stable polymorphous forms of rifaximin201910,258,657Therapeutic and nutritional compositions for functional gastrointestinal disorders201910,258,610Pharmaceutical compositions comprising rifaximin, processes for their preparation and their use in the treatment of vaginal infections20199,938,298Solvated crystal form of rifaximin, production, compositions and uses thereof20189,725,466'Rifaximin derivative and uses thereof'20179,700,545'Forms of rifaximin and uses thereof'20179,498,442'Rifaximin powder, process for preparing the same an controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect'20169,452,157'Pharmaceutical compositions comprising rifaximin and amino acids, preparation methods and use thereof'20169,364,467'Rifaximin derivative and uses thereof'20169,359,357'Forms of rifaximin and uses thereof'20169,271,968'Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations'20169,181,274'Forms of rifaximin and uses thereof'20159,035,046'Rifaximin derivative and uses thereof'20158,987,231'Sulodexide for use in the treatment of pathologies wherein metalloproteinases are involved'20158,853,231'Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin'20148,835,452'Polymorphic forms α, β and γ of rifaximin'20148,748,449'Use of polyols to obtain stable polymorphous forms of rifaximin'20148,748,447'Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect'20148,741,904'Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations'20148,568,782'Gastroresistant pharmaceutical formulations containing rifaximin'20138,518,949'Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations'20138,404,704'Use of polymorphic forms of rifaximin for medical preparations'20138,318,763'Rifamycin derivatives'20128,217,054'Use of polyols to obtain stable polymorphous forms of rifaximin'20128,193,196'Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations'20128,173,801'Processes for the production of polymorphic forms of rifaximin'20128,158,781'Polymorphic forms α, β and γ of rifaximin'20128,158,644'Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin'20127,923,553'Processes for the production of polymorphic forms of rifaximin'20117,915,275'Use of polymorphic forms of rifaximin for medical preparations'20117,906,542'Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin'20117,902,206'Polymorphic forms α, β and γ of rifaximin'20117,045,620'Polymorphous forms of rifaximin, processes for their production and use thereof in medicinal preparations'20066,866,782'Process for the purification of pharmacologically active proteins through cationic exchange chromatography'20055,244,655'Process for the purification of recombinant human beta interferon, beta interferon thus purified and pharmaceutical compositions which contain it'19935,043,423'Method for purifying low molecular weight compounds of peptide or pseudo-peptide structure'19915,021,600'New silylating agent for the preparation of chromatographic supports'19914,638,046'Retro-inverso C-terminal hexapeptide analogues of substance P'19874,439,360'Retro-inverso analogues of C-terminal penta and hexapeptides of Substance P'1984

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1984–1991Based in Monterotondo, IT· patent location history
1987Based in Rome, IT· patent location history
1991–1993Based in Siena, IT· patent location history
2005–2019Patents assigned to ALFA WASSERMANN SPA (30)· patent assignee history
2005–2020Based in Sasso Marconi, IT· patent location history
2006–2020Based in Bologna, IT· patent location history
2012–2019Patents assigned to VISCOMI GIUSEPPE CLAUDIO (15)· patent assignee history
2012–2013Patents assigned to CAMPANA MANUELA (7)· patent assignee history
2012–2014Patents assigned to CONFORTINI DONATELLA (7)· patent assignee history
2019–2020Patents assigned to ALFASIGMA SPA (7)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ALFA WASSERMANN SPA302005–2019
VISCOMI GIUSEPPE CLAUDIOself152012–2019
ALFASIGMA SPA72019–2020
CAMPANA MANUELA72012–2013
CONFORTINI DONATELLA72012–2014
Locations
LocationPatentsSpan
Bologna, IT322006–2020
Sasso Marconi, IT62005–2020
Siena, IT21991–1993
Monterotondo, IT21984–1991
Rome, IT11987